Balance Sheet for Proteostasis Therapeutics Inc. (PTI)

$ 1.11   -0.03 (-2.63%) Volume: 171.37k 10:15 AM EDT 1-Apr-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 25,008 28,810 29,724 18,613 13,844
Restrictable Cash - - 294 - -
Marketable Securities 44,459 89,569 44,738 66,897 -
Accounts Receivable - - 2,519 668 918
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - 2,519 668 918
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 1,404 2,481 1,377 4,059 180
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - 180
Total Current Assets 70,871 120,860 76,133 90,237 14,942
Land and Improvements - - - - -
Buildings and Improvement - - 382 382 364
Machinery, Furniture and Equipment 3,106 3,292 3,625 3,482 3,219
Construction in Progress - 8 - - -
Fixed Assets, Other 12,631 13,849 90 - -
Fixed Assets, Total 15,737 17,149 4,097 3,864 3,583
Gross Fixed Assets 15,737 17,149 4,097 3,864 3,583
Accumulated Depreciation (2,712) (2,695) (3,201) (3,323) (3,017)
Net Fixed Assets 13,025 14,454 896 541 566
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 828 828 1,689 362 438
Total Non-Current Assets 13,853 15,282 2,585 903 3,748
Total Assets 84,724 136,142 78,718 91,140 18,690
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 2,283 1,884 2,098 2,021 3,330
Short Term Debt 1,153 1,056 559 - -
Notes Payable - - - - -
Accrued Expenses 6,864 5,661 6,120 4,328 2,248
Accrued Liabilities 6,864 5,661 6,120 4,328 2,248
Deferred Revenues - - 1,108 2,204 4,076
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - 201 182
Total Current Liabilities 10,300 8,601 9,885 8,754 9,836
Long Term Debt 12,043 13,196 - - -
Deferred Income Tax - - 263 839 4,552
Other Non-Current Liabilities 3 3 25 930 (107,628)
Minority Interest - - - - -
Capital Lease Obligations 12,043 13,196 - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 12,046 13,199 25 930 4,664
Total Liabilities 22,346 21,800 9,910 9,684 14,500
Preferred Shareholder's Equity - - - - 112,292
Common Shareholder's Equity 62,378 114,342 68,808 81,456 (108,102)
Common Par 52 51 35 26 1
Additional Paid in Capital 398,979 391,825 285,583 238,902 12,115
Cumulative Translation Adjustments - - - - -
Retained Earnings (336,660) (277,535) (216,808) (157,450) (120,218)
Treasury Stock - - - - -
Other Equity Adjustments 7 1 (2) (22) -
Total Capitalization 62,378 114,342 68,808 81,456 4,190
Total Equity 62,378 114,342 68,808 81,456 4,190
Total Liabilities & Shareholder's Equity 84,724 136,142 78,718 91,140 18,690
Cash Flow (59,581) (63,172) (61,012) (38,993) (36,490)
Working Capital 60,571 112,259 66,248 81,483 5,106
Free Cash Flow (53,231) (59,259) (52,513) (42,154) (19,678)
Invested Capital 62,378 114,342 68,808 81,456 4,190
Shares Outstanding - Common Class Only 52,117 50,808 34,416 25,001 -
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 52,117 50,808 34,416 25,001 16,711
Total Common Shares Outstanding 52,117 50,808 34,416 25,001 -
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 51,140 38,495 25,408 18,759 16,711
Diluted Weighted Shares Outstanding 51,140 38,495 25,408 18,759 16,711